Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Main Authors: | Ke Yang, Yifan Chen, Kenneth Kin Wah To, Fang Wang, Delan Li, Likun Chen, Liwu Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-06-01
|
Series: | Experimental and Molecular Medicine |
Online Access: | https://doi.org/10.1038/s12276-020-0453-6 |
Similar Items
-
Reversal of ABCB1-related multidrug resistance by ERK5-IN-1
by: Fang Wang, et al.
Published: (2020-03-01) -
Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo
by: Zhiqiang Zhang, et al.
Published: (2019-09-01) -
VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
by: Ning Ji, et al.
Published: (2018-10-01) -
Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells
by: Weiguo Feng, et al.
Published: (2020-06-01) -
Ceritinib Enhances the Efficacy of Substrate Chemotherapeutic Agent in Human ABCB1-Overexpressing Leukemia Cells In Vitro, In Vivo and Ex-Vivo
by: Li Yang, et al.
Published: (2018-05-01)